FDA approvals

Another medium molecule hits the market
August 8, 2019

Bremelanotide (commercialized as Vyleesi) has recently been approved by the FDA for the treatment of low sexual desire in women.

Read More
Macrocycles
Review of the Month: Opportunities with Macrocycles
June 26, 2019

The macrocycles provides access to new chemical space and opportunities in drug discovery that are otherwise difficult to reach with small molecules.

Read More
Lorcaserin approved
June 29, 2012

Well, it is the first anti-obesity drug approved by the FDA in 13 years (last one was Roche’s Orlistat, marketed as Xenical…

Read More